NCT06842875 Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
| NCT ID | NCT06842875 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Women and Infants Hospital of Rhode Island |
| Condition | Hypertension in Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,536 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2029-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,536 participants in total. It began in 2025-04-15 with a primary completion date of 2029-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
Eligibility Criteria
Inclusion Criteria: * Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island * Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant * English-, Spanish-, Portuguese-, or Haitian-Creole-speaking * Smartphone ownership Exclusion Criteria: * Prior enrollment in this trial * Prisoners or incarcerated people * Inability or unwillingness to provide informed consent * Inability to communicate with study team, despite an interpreter
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06842875 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 60 Years, studying Hypertension in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06842875 currently recruiting?
Yes, NCT06842875 is actively recruiting participants. Contact the research team at snunez@wihri.org for enrollment information.
Where is the NCT06842875 trial being conducted?
This trial is being conducted at Newport, United States, Providence, United States, Wakefield, United States, Warwick, United States and 1 additional location.
Who is sponsoring the NCT06842875 clinical trial?
NCT06842875 is sponsored by Women and Infants Hospital of Rhode Island. The trial plans to enroll 1,536 participants.